Skip to main content
. 2010 Dec 7;25(2):341–347. doi: 10.1038/leu.2010.226

Table 2. Response to everolimus by disease type.

Disease type N ORR (95% CI) CR PR
Total 77 30% (20–41) 3 20
DLBCL 47 30% (17–45) 0 14
MCL 19 32% (13–57) 2 4
FL-III 8 38% (9–76) 1 2
Other 3 0 0 0

Abbreviations: CI, confidence interval; CR, complete remission; DLBCL, diffuse large B-cell lymphoma; FL-III, follicular lymphoma grade III; MCL, mantle cell lymphoma; ORR, overall response rate; PR, partial remission.